Clinical trial
Prevalence Analysis of Ocular Disorders in Patients on Treatment for Symptomatic Multiple Myeloma
NCT02917239 is registered in ClinicalTrials.gov with Fondazione IRCCS Istituto Nazionale dei Tumori, Milano as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence Analysis of Ocular Disorders in Patients on Treatment for Symptomatic Multiple Myeloma
- Lead sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- September 30, 2016
- Enrollment
- 100 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.